Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIMEDX GROUP, INC.MDXG · Entity 5271 | General Counsel and CAO | March 13, 2026 | March 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIMEDX GROUP, INC.
Report date March 13, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 543,195 |
Reported balance
After 2026-03-13 transaction · row 1
1 source rowRow 1 · 2026-03-13 · Tax withholding · Disposed 20,245 · Balance 543,195 F1: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2026 Filed Mar 17, 2026 22:32 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 20,245 | $4.38 | $88,673.10 |
DisclosureSEC source: 0001796044-26-000009 · wk-form4_1773786746.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 543,195 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:35 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 61,460 | $4.50 | $276,570.00 |
DisclosureSEC source: 0001796044-26-000007 · wk-form4_1773351342.xml · nonDerivative · entry 2 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563,440 F2 · shares: The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:35 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Exercise / conversionCommon Stock | 136,364 | $4.50 | $613,638.00 |
DisclosureSEC source: 0001796044-26-000007 · wk-form4_1773351342.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on March 13. 2023. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:45 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 62,758 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001796044-26-000005 · wk-form4_1772837155.xml · derivative · entry 2 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,190 Underlying: Common Stock · 62,758 shares Expires 2033-03-03 F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:45 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 74,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001796044-26-000005 · wk-form4_1772837155.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,536 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
| May 08, 2025 Filed May 16, 2025 21:48 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 8,877 | $7.42 | $65,867.34 |
DisclosureSEC source: 0001376339-25-000055 · wk-form4_1747432124.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,549 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 22:03 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 8,876 | $6.76 | $60,001.76 |
DisclosureSEC source: 0001376339-25-000036 · wk-form4_1745618577.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,426 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| April 08, 2025 Filed Apr 10, 2025 22:01 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 8,876 | $6.86 | $60,889.36 |
DisclosureSEC source: 0001628280-25-017382 · wk-form4_1744322490.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,302 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:58 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 20,366 | $7.89 | $160,687.74 |
DisclosureSEC source: 0001376339-25-000031 · wk-form4_1741989487.xml · nonDerivative · entry 2 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,178 F2 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:58 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 34,230 | $7.89 | $270,074.70 |
DisclosureSEC source: 0001376339-25-000031 · wk-form4_1741989487.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,544 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted performance stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:56 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 81,446 | $7.80 | $635,278.80 |
DisclosureSEC source: 0001376339-25-000027 · wk-form4_1741823803.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,774 F1 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $7.74 to $7.96, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:59 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 36,891 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001376339-25-000021 · wk-form4_1741219161.xml · derivative · entry 3 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,432 Underlying: Common Stock · 36,891 shares Expires 2032-03-03 F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:59 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 46,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-25-000021 · wk-form4_1741219161.xml · nonDerivative · entry 2 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 576,220 F2 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:59 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 76,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-25-000021 · wk-form4_1741219161.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529,781 F1 · shares: Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2022 to December 31, 2024. The PSUs were granted on April 8, 2022. Read SEC document |
| May 08, 2024 Filed May 9, 2024 22:46 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 8,896 | $7.20 | $64,051.20 |
DisclosureSEC source: 0001376339-24-000035 · wk-form4_1715294786.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,271 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 21:31 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 8,896 | $6.51 | $57,912.96 |
DisclosureSEC source: 0001376339-24-000030 · wk-form4_1713994253.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 462,167 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| April 08, 2024 Filed Apr 10, 2024 21:43 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 8,896 | $6.90 | $61,382.40 |
DisclosureSEC source: 0001376339-24-000028 · wk-form4_1712785389.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,063 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 22:35 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 20,381 | $7.95 | $162,028.95 |
DisclosureSEC source: 0001376339-24-000019 · wk-form4_1710542093.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,959 F1 · shares: shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:28 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 15,351 | $8.26 | $126,799.26 |
DisclosureSEC source: 0001376339-24-000017 · wk-form4_1709681274.xml · nonDerivative · entry 2 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,340 F2 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:28 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 71,541 | $0.00 Strike: $8.63 | $0.00 |
DisclosureSEC source: 0001376339-24-000017 · wk-form4_1709681274.xml · derivative · entry 3 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,541 Underlying: Common Stock · 71,541 shares Expires 2031-03-01 F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:28 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 59,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-24-000017 · wk-form4_1709681274.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 515,691 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:58 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,870 | $5.93 | $34,786.21 |
DisclosureSEC source: 0001376339-23-000030 · wf-form4_168393230325038.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 456,564 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 23:23 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,988 | $3.74 | $22,419.07 |
DisclosureSEC source: 0001796044-23-000006 · wf-form4_168263777428764.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 462,434 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 21:39 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,995 | $3.31 | $19,843.45 |
DisclosureSEC source: 0001796044-23-000005 · wf-form4_168142193153985.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468,422 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 22:16 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 136,364 | $4.62 | $630,001.68 |
DisclosureSEC source: 0001796044-23-000004 · wf-form4_167891857858450.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,417 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 22:40 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 11,308 | $4.24 | $47,997.94 |
DisclosureSEC source: 0001796044-23-000003 · wf-form4_167840161646606.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,053 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 22:36 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 15,555 | $4.53 | $70,476.59 |
DisclosureSEC source: 0001796044-23-000002 · wf-form4_167727817921896.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,361 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $4.520 to $5.535, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 21:29 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 178,571 | $4.62 | $824,998.02 |
DisclosureSEC source: 0001376339-22-000044 · wf-form4_164979897149747.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,916 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:25 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 9,990 | $4.86 | $48,541.41 |
DisclosureSEC source: 0001376339-22-000022 · wf-form4_164694741185779.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,345 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:05 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 13,500 | $4.41 | $59,535.00 |
DisclosureSEC source: 0001796044-22-000002 · wf-form4_164582667565948.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,335 F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:19 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 99,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001796044-21-000004 · wf-form4_161523834719598.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,835 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:03 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 10,231 | $9.81 | $100,366.11 |
DisclosureSEC source: 0001796044-21-000002 · wf-form4_161402422041612.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,531 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:43 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 120,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001796044-20-000002 · wf-form4_159674658085433.xml · nonDerivative · entry 1 Hulse William Frank IV · CIK 0001796044 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,762 F1 · price: On August 5, 2020, the Company fixed the number of shares subject to previously-awarded restricted units based on the closing stock price on that date ($5.90). Award will be settled in common stock upon vesting. One-third of the award vests upon each anniversary of the original grant date, February 18, 2020. Grant is exempt under rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.